Alpha 2.0
Login Register
» Articles » PMID: 2743719

Unusual Eye Manifestations in Systemic Lupus Erythematosus Patients

Overview
Journal Clin Rheumatol
Publisher Springer
Specialty Rheumatology
Date 1989 Mar 1
PMID 2743719
Citations 6
Authors
A A Drosos
C A Petris
G M Petroutsos
H M Moutsopoulos
Affiliations
Soon will be listed here.
Abstract

One hundred and twelve records of patients with systemic lupus erythematosus were reviewed and four cases with unusual ocular manifestations are described. We found that anterior uveitis is not an uncommon manifestation of systemic lupus erythematosus and physicians must be aware of it during the patient's evaluation, since it can be treated without serious visual loss. Optic neuritis is uncommon in systemic lupus erythematosus and visual loss may be permanent despite therapy.

Citing Articles

Intravenous immunoglobulin in eye involvement.

Tellier Z Clin Rev Allergy Immunol. 2006; 29(3):295-306.

PMID: 16391405 DOI: 10.1385/CRIAI:29:3:295.

Successful treatment of optic neuropathy in association with systemic lupus erythematosus using intravenous cyclophosphamide.

Rosenbaum J, Simpson J, Neuwelt C Br J Ophthalmol. 1997; 81(2):130-2.

PMID: 9059246 PMC: 1722112. DOI: 10.1136/bjo.81.2.130.

Ischaemic optic neuropathy, transverse myelitis, and epilepsy in an anti-phospholipid positive patient with systemic lupus erythematosus.

Cordeiro M, Lloyd M, Spalton D, Hughes G J Neurol Neurosurg Psychiatry. 1994; 57(9):1142-3.

PMID: 8089695 PMC: 1073153. DOI: 10.1136/jnnp.57.9.1142.

Autoimmune multiorgan involvement in elderly men is it SLE?.

Aharon A, Zandman-Goddard G, Shoenfeld Y Clin Rheumatol. 1994; 13(4):631-4.

PMID: 7697969 DOI: 10.1007/BF02243008.

Acquired Brown's syndrome in systemic lupus erythematosus: another ocular manifestation.

McGalliard J, Bell A Clin Rheumatol. 1990; 9(3):399-400.

PMID: 2261741 DOI: 10.1007/BF02114403.

References
1.
Moutsopoulos H, Skopouli F, Sarras A, Tsampoulas C, Mavridis A, Constantopoulos S . Anti-Ro(SSA) positive rheumatoid arthritis (RA): a clinicoserological group of patients with high incidence of D-penicillamine side effects. Ann Rheum Dis. 1985; 44(4):215-9. PMC: 1001615. DOI: 10.1136/ard.44.4.215. View
2.
Hochberg M, Boyd R, Ahearn J, Arnett F, Bias W, Provost T . Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore). 1985; 64(5):285-95. View
3.
Halberg P, Alsbjorn B, Balslev J, Lorenzen I, Gerstoft J, Ullman S . Systemic lupus erythematosus. Follow-up study of 148 patients. II: Predictive factors of importance for course and outcome. Clin Rheumatol. 1987; 6(1):22-6. DOI: 10.1007/BF02200996. View
4.
Wong K, Ai E, Jones J, Young D . Visual loss as the initial symptom of systemic lupus erythematosus. Am J Ophthalmol. 1981; 92(2):238-44. DOI: 10.1016/0002-9394(81)90779-0. View
5.
Gold D, FEINER L, Henkind P . Retinal arterial occlusive disease in systemic lupus erythematosus. Arch Ophthalmol. 1977; 95(9):1580-5. DOI: 10.1001/archopht.1977.04450090102008. View